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Abstract
Variant late-infantile neuronal ceroid lipofuscinosis (vLINCL), caused by CLN6 mutation, and juvenile neuronal ceroid
lipofuscinosis (JNCL), caused by CLN3 mutation, share clinical and pathological features, including lysosomal accumulation
of mitochondrial ATP synthase subunit c, but the unrelated CLN6 and CLN3 genes may initiate disease via similar or distinct
cellular processes. To gain insight into the NCL pathways, we established murine wild-type and CbCln6
nclf/nclf cerebellar cells
and compared them to wild-type and CbCln3
Dex7/8/Dex7/8 cerebellar cells. CbCln6
nclf/nclf cells and CbCln3
Dex7/8/Dex7/8 cells
both displayed abnormally elongated mitochondria and reduced cellular ATP levels and, as cells aged to confluence,
exhibited accumulation of subunit c protein in Lamp 1-positive organelles. However, at sub-confluence, endoplasmic
reticulum PDI immunostain was decreased only in CbCln6
nclf/nclf cells, while fluid-phase endocytosis and LysoTrackerH
labeled vesicles were decreased in both CbCln6
nclf/nclf and CbCln3
Dex7/8/Dex7/8 cells, though only the latter cells exhibited
abnormal vesicle subcellular distribution. Furthermore, unbiased gene expression analyses revealed only partial overlap in
the cerebellar cell genes and pathways that were altered by the Cln3
Dex7/8 and Cln6
nclf mutations. Thus, these data support
the hypothesis that CLN6 and CLN3 mutations trigger distinct processes that converge on a shared pathway, which is
responsible for proper subunit c protein turnover and neuronal cell survival.
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Introduction
The neuronal ceroid lipofuscinoses (NCLs) collectively account
for most cases of childhood-onset neurodegenerative disease
worldwide, with clinical features of blindness, seizures, psychosis,
motor and cognitive decline, and premature death (see recent
reviews [1,2]). A defining feature of NCL is lysosomal storage of
autofluorescent ceroid lipofuscin, which contains proteolipid and
dolichols, and in most forms of NCL, the mitochondrial ATP
synthase, subunit c protein [2,3,4,5].
Childhood-onset NCL is recessively inherited, and rare
recessive and dominant adult-onset forms of NCL have also been
described [2,6,7,8]. To date, 10 genetic loci are linked to NCL,
and it is likely more are yet to be discovered [2,6]. The genes
linked to NCL encode proteins primarily localized to either acidic
organelles (late endosomes and lysosomes) or to the endoplasmic
reticulum (ER). Several of the proteins are enzymes (PPT1, TPPI,
cathepsin D), but the others are novel, mostly transmembrane
proteins, with no known function (see recent reviews [2,6,9]).
Given the overlapping clinical symptoms and disease pathology
in the different forms of NCL, it has been proposed that the NCL
genes encode proteins that function together or at different points
in a common pathway, which most likely involves lipid and protein
trafficking pathways and/or ion homeostasis [2,9]. Consistent with
this hypothesis, protein-protein interaction between several NCL-
linked proteins has been implicated by studies in overexpression or
pull-down assay systems [10,11], and cross-correction of growth
defects in patient cells by other CLN genes has been described [12].
However, clinical and pathological differences in the different
NCL sub-types are also recognized, including distinctive ultra-
structure of the storage material and differences in the age at onset
and order of symptom onset [1,13,14,15].
The most common form of NCL, with juvenile onset (JNCL), is
caused by CLN3 mutation [16]. The CLN3 gene encodes a novel
multipass transmembrane protein (battenin or CLN3p) that
primarily localizes to the late endosome and lysosome in most
cell types. CLN3p is implicated in regulation of lysosomal pH
[17,18], endocytosis [19,20,21], autophagy [22,23], cell growth
and survival [24,25], palmitoyl desaturase activity [26], and
lysosome-targeted protein trafficking [20,27]. However, the
precise protein activity of CLN3p remains unknown.
CLN6 mutation causes a non-classical, hence ‘variant’, late-
infantile NCL (vLINCL) [28,29]. The CLN6-encoded protein,
linclin or CLN6p, encodes an ER-resident, multipass transmem-
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studied, it is also implicated in trafficking and regulating lysosomal
function [30,31].
We previously established genetically precise murine and cell-
based models for JNCL, Cln3
Dex7/8 mice and CbCln3
Dex7/8
cerebellar cells [20,32]. Here, we have created an analogous
cellular model from Cln6
nclf spontaneous mutant mice, originally
identified at The Jackson Laboratories [33], which harbor a
mutation in the murine Cln6 gene that is also found in vLINCL
patients [28,29]. With this set of genetic cell culture reagents, we
have performed detailed, comparative phenotyping in order to
determine the degree of overlap in abnormal cellular processes
resulting from distinct NCL mutations.
Results
CbCln3
Dex7/8 and CbCln6
nclf neuronal precursor cell lines
We previously established CbCln3
Dex7/8 neuronal precursor cell
lines by conditionally immortalizing cerebellar granule neurons
from postnatal wild-type, heterozygous or homozygous littermate
Cln3
Dex7/8 mice [20]. These mice bear a ,1 kb genomic deletion in
the endogenous murine Cln3 gene that is analogous to the most
common ,1 kb genomic deletion in juvenile NCL patients. To
permit a comparison of the effects of the vLINCL mutation, we
have now created wild-type, heterozygous, and homozygous
CbCln6
nclf neuronal precursor cell lines from postnatal Cln6
nclf mice
[33], which bear a frameshift-producing, single base-pair insertion
in the murine Cln6 gene, which is also found in human vLINCL
patients [28,29]. The generation of the murine vLINCL cell panel is
described in detail in Materials and Methods, along with the
characterization demonstrating expression of the neural stem cell
marker, nestin, confirming a neuronal lineage (Figure S1).
Homozygous CbCln6
nclf and CbCln3
Dex7/8 cells
accumulate ATP synthase, subunit c
The pathological hallmark of NCL is an abnormal lysosomal
accumulation of the pore-forming subunit c of the mitochondrial
F0 ATP synthase complex. At sub-confluent density, a mitochon-
drial marker, anti-grp75, which has revealed significant elongation
of mitochondria in homozygous CbCln3
Dex7/8 cells [20] (mean
circularity index 0.816.002), also revealed abnormally elongated
mitochondria in homozygous CbCln6
nclf cerebellar cells (mean
circularity index 0.796.003), compared to wild-type cells
(CbCln3
+/+ or CbCln6
+/+; mean circularity index 0.856.002)
(Figure 1A). Similar to homozygous CbCln3
Dex7/8 cells, the
homozygous CbCln6
nclf cerebellar cells also displayed a significant
reduction (,30–40%, p#.01) in total cellular ATP levels, relative
to wild-type or heterozygous cells (Figure 1B), strongly suggesting
altered mitochondrial morphology and function.
Homozygous CbCln3
Dex7/8 cells, when aged at confluent cell
density, accumulated subunit c-positive puncta [20]. Assessment of
the wild-type and CbCln6
nclf cerebellar cells revealed subunit c-
positive puncta in aged homozygous mutant CbCln6
nclf cerebellar
cells, similar to that observed in the aged homozygous CbCln3
Dex7/8
cells (Figure 2). Consistent with the abnormal accumulation
occurring in a lysosomal compartment, little to no overlap of
subunitc signal wasobserved with mitochondrial grp75 inconfluent
aged homozygous CbCln3
Dex7/8 cells and only limited overlap of the
subunit c and grp75 immunostain was observed in the confluent
aged homozygous CbCln6
nclf cerebellar cells (Figure 2A), while the
subunit c immunostain in confluent aged wild-type cells exhibited
moderate overlap with grp75 immunostain (Figure 2A). Moreover,
in the aged wild-type cerebellar cells, the subunit c immunostain did
not overlap with Lamp 1 immunostain, whereas the strongly
immunopositive subunit c puncta in both the homozygous
CbCln3
Dex7/8 and CbCln6
nclf cerebellar cells aged at confluent
density were Lamp 1-positive (Figure 2B), though the overlap was
imperfect, particularly in the homozygous CbCln6
nclf cerebellar
cells. In both homozygous CbCln3
Dex7/8 and CbCln6
nclf cells aged at
confluent density, the Lamp 1 immunostain also revealed enlarged
or aggregated lysosomes, which were not often observed in the aged
wild-type cells, consistent with lysosomal defects.
Thus, cerebellar cells homozygous for either a vLINCL
mutation or the major JNCL mutation exhibited aberrant
mitochondrial morphology and, when aged at confluent density,
accumulated mitochondrial ATP synthase subunit c in enlarged,
Lamp 1-positive vesicles, albeit with slightly different staining
characteristics.
Homozygous CbCln6
nclf and CbCln3
Dex7/8 cells display
similar but distinct membrane abnormalities
To determine whether similar accumulation of subunit c in
Lamp 1-positive vesicles, might reflect similar or distinct
membrane organelle perturbations, CbCln6
nclf/nclf and
CbCln3
Dex7/8/Dex7/8 cerebellar cells were assessed using a panel
of organelle markers [20]. We found no obvious morphological
differences in the cis- and trans-Golgi in either homozygous
CbCln3
Dex7/8 or CbCln6
nclf cerebellar cells (data not shown).
However, the ER marker protein, PDI, consistently displayed
reduced staining intensity in homozygous CbCln6
nclf cerebellar
cells, compared to wild-type (CbCln6
+/+) cells (Figure 3, top
panels). Homozygous CbCln3
Dex7/8 cells did not display altered
PDI immunostain (Figure 3). Interestingly, immunostain for
another ER-associated protein, BiP [34], was not decreased in
homozygous CbCln6
nclf cerebellar cells and highlighted a mor-
phologically intact ER network (Figure 3). Notably, PDI
immunostain was also decreased in variant late-infantile NCL
patient lymphoblast cells, compared to normal lymphoblasts
(Figure 3, bottom panels), suggesting that the vLINCL mutation
may specifically alter PDI epitope availability or distribution
within the ER of diverse cell types. Total PDI levels were not
obviously different in the homozygous CbCln6
nclf cerebellar cells
versus wild-type cells by immunoblot analysis (data not shown).
To determine whether subconfluent, non-stressed CbCln6
nclf
cerebellar neuronal precursor cells displayed abnormalities in the
endosomal-lysosomal system, which is significantly disrupted in
subconfluent homozygous CbCln3
Dex7/8 cells [20], we assayed fluid
phase endocytosis using a fluorescently labeled dextranuptake assay
(dextran,AlexaFluorH 488)andacidicorganelleswereprobed using
LysoTrackerH Red. As expected, homozygous CbCln3
Dex7/8 cells
showed consistently reduced numbers of dextran-Alexa 488 labeled
vesicles and LysoTrackerH stained vesicles, along with a reduced
perinuclear distribution of the labeled vesicles, compared to wild-
type (CbCln3
+/+) or heterozygous (CbCln3
+/Dex7/8) cells (Figure 4).
Homozygous CbCln6
nclf cells also showed consistently reduced
dextran-Alexa 488 labeled vesicles and LysoTrackerH stained
vesicles, compared to wild-type (CbCln6
+/+) or heterozygous
(CbCln6
+/nclf) cells. However, in contrast to what was observed in
homozygous CbCln3
Dex7/8 cells, the distribution of the labeled
vesicles in homozygous CbCln6
nclf cells was not obviously altered
(Figure 4A). Notably, the expanded and/or aggregated lysosomal
compartment, which was evident by Lamp 1 immunostain in the
confluent density aged homozygous CbCln3
Dex7/8 and CbCln6
nclf
cells, as shown in Figure 2B, was not observed in the subconfluent,
Lysotracker-stained homozygous CbCln3
Dex7/8 and CbCln6
nclf cells
here. Automated image analysis demonstrated that the numbers of
labeled vesicles were more dramatically decreased (p,.001) in the
homozygous CbCln3
Dex7/8 cells (,65–75% reduced from wild-type
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nclf cells (,35–50% reduced
from wild-type levels) (Figure 4B).
Homozygous CbCln3
Dex7/8 and CbCln6
nclf cerebellar cells
exhibit mostly distinct gene expression changes
The membrane organelle survey revealed similarities but also
differences in the impact of the vLINCL and JNCL mutations that
implied distinct underlying processes might be involved. To assess
this idea at the molecular level, we performed unbiased global
gene expression analyses on total RNA isolated from wild-type
(CbCln3
+/+ and CbCln6
+/+) and homozygous CbCln3
Dex7/8 and
CbCln6
nclf cerebellar cells (see Materials and Methods).
In a probe-level analysis, we identified 981 significantly changed
probes in the homozygous CbCln3
Dex7/8 cerebellar cells (p,.01,
absolute fold-change.1.5; Figure 5, Table S1) and 718 signifi-
cantly changed probes in the homozygous CbCln6
nclf cerebellar
cells (p,.01, absolute fold-change.1.5; Figure 5, Table S2).
Among these, only a small number, 36 probes, were significantly
changed in both homozygous CbCln3
Dex7/8 and CbCln6
nclf cells,
with the majority (28) discordant in the direction of change
(Figure 5, Table 1). The reliability of the datasets was assessed by
principal components analysis (PCA) (Figure S2) and real-time
qRT-PCR of selected genes (Table S3).
Gene ontology analysis of the gene lists did not reveal obvious
functional overlap among the genes with altered expression in
both CbCln3
Dex7/8/Dex7/8 and CbCln6
nclf/nclf cells, suggesting the
pathways most dramatically affected by the Cln3
Dex7/8 and Cln6
nclf
mutations were mostly different (Tables S4 and S5). PCA analysis
of the CbCln3
Dex7/8 significant probes in the CbCln6
nclf dataset,
and vice versa, further supported this conclusion (Figure S3).
Notably, in our Affymetrix gene expression array analysis, Cln3
and Cln6 gene expression were not significantly altered by the
vLINCL and JNCL mutations, respectively (Tables S1 and S2).
Figure 1. Mitochondrial abnormalities in homozygous CbCln6
nclf and CbCln3
Dex7/8 cells. A. Representative micrographs of wild-type,
CbCln3
Dex7/8/Dex7/8 and CbCln6
nclf/nclf cells immunostained with antibody recognizing the mitochondrial matrix protein, grp75, are shown. Note the
elongated appearance of mitochondria in homozygous CbCln3
Dex7/8 and CbCln6
nclf cells, compared to wild-type cells in the zoomed insets. A lower
magnification of a representative field of cells is also shown to demonstrate the subconfluent culture conditions. The altered mitochondrial
morphology was also quantified by automated image analysis, showing a significantly reduced circularity index of the labeled mitochondria in the
mutant cells, compared to wild-type cells (see Results). Wild-type panel is representative of both CbCln3
+/+ and CbCln6
+/+ cell lines. Heterozygous cell
lines were indistinguishable from wild-type (not shown). All images were captured at 406 magnification and were taken on the same day with
identical settings. B. The bar graph depicts relative total cellular ATP levels in wild-type, heterozygous, or homozygous CbCln3
Dex7/8 and CbCln6
nclf
cells, determined using the CellTiter-GLOH Luminescent Cell assay. Relative luciferase units were normalized to the wild-type cell lines and were
pooled from 2–3 independent assays per cell line, each tested in 3–10 wells per assay. For reference, absolute RLUs for CbCln3
+/+ and CbCln6
+/+ cell
lines were 1995830627506 and 6261726151671, respectively. *, p#.01 in a Student’s t-test; n.s.=not significant.
doi:10.1371/journal.pone.0017118.g001
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expression of mutant Cln3 mRNA in CbCln3
Dex7/8/Dex7/8
cerebellar cells (5-fold downregulated), consistent with previous
reports [20,32], and reduced expression of mutant Cln6 mRNA in
CbCln6
nclf/nclf cerebellar cells (6-fold downregulated). We also
detected a 1.6-fold upregulation of Cln6 mRNA in homozygous
CbCln3
Dex7/8 cells and an ,2-fold downregulation of Cln3 mRNA
in homozygous CbCln6
nclf cerebellar cells by qRT-PCR (Table
S3). This apparent discrepancy between the Affymetrix array and
qRT-PCR data at the level of the Cln3 and Cln6 genes could be
due to the gene regions being probed in the two different formats,
which differed (e.g. reflecting detection of different splice variants),
or the different sensitivities of the two methodologies. Among the
other NCL loci represented on the Affymetrix array (Ppt1, Tpp1,
Cln5, Mfsd8, Ctsd, Cln8), only Cln5, which is mutated in another
form of non-classical ‘variant’ LINCL [35], displayed a significant
change (1.8-fold upregulated), and only in the homozygous
CbCln3
Dex7/8 cells (Table S1).
Though our probe-level analysis suggested only limited overlap
in the genes affected by the Cln3
Dex7/8 and Cln6
nclf mutation, we
also sought to examine the data at a pathways level. Gene Set
Enrichment Analysis (GSEA) has proven to be a sensitive method
of identifying pathways relevant to human disease from gene
expression datasets (e.g. [36,37,38,39]). GSEA is predicated on the
idea that genes with related biological functions are oftentimes
coordinately regulated, and that even small gene expression
changes, which escape identification through traditional single
gene analysis approaches, are biologically meaningful if in the
context of related gene changes [36,40]. We further analyzed our
unbiased gene expression data in the sigPathway program, which
is an extension of the original GSEA platform [41], using our
entire CbCln3
Dex7/8 and CbCln6
nclf datasets.
The significantly altered gene sets (false discovery rate,0.01) in
homozygous CbCln3
Dex7/8 and CbCln6
nclf cells are shown in Tables
S6 and S7, respectively. Overall, more changed gene sets (597 out of
2077 total screened) were identified in the homozygous CbCln6
nclf
cerebellar cells than in the homozygous CbCln3
Dex7/8 cells (222 out
of 2077 total screened). Consistent with our probe-level analysis
results, inspection of the top 20 ranked (NTk Rank) gene sets, which
reflected those gene sets determined by the sigPathway software to
have the most changes among all gene sets screened (see Materials
and Methods and [41]), revealed limited overlap in the most
dramatically changed pathways in the CbCln3
Dex7/8/Dex7/8 and
CbCln6
nclf/nclf cells (Tables 2 and 3). Only the gene set for the
oxidative phosphorylationKEGG pathway scoredwithinthe top 20
ranks for both the homozygous CbCln3
Dex7/8 (NTk Rank=1) and
CbCln6
nclf (NTk Rank=17) gene set lists. However, supporting the
notion that there is convergence in the biological processes affected
by the JNCL and vLINCL mutations, further inspection of the
complete lists of significantly changed gene sets in the two different
Figure 3. Altered PDI immunostain in homozygous CbCln6
nclf cells. Representative micrographs of CbCln6 (CbCln6
+/+ and CbCln6
nclf/nclf) and
CbCln3 cells (CbCln3
Dex7/8/Dex7/8;C b Cln3
+/+) immunostained for the ER marker protein PDI (red) are shown. Note the decreased PDI signal in
CbCln6
nclf/nclf cells, as compared to wild-type (CbCln6
+/+ or CbCln3
+/+) and CbCln3
Dex7/8/Dex7/8 cells. PDI immunostain of normal and variant late-
infantile (vLINCL) lymphoblast cells is also shown. BiP immunostain was comparable across all of the cerebellar cell lines, but is only shown for the
CbCln6
+/+ and CbCln6
nclf/nclf cells. BiP was not assessed in lymphoblast cells. All images were taken at 406magnification, and for like stains, on the
same day, with identical instrument settings. DAPI nuclear counter stain is shown in blue.
doi:10.1371/journal.pone.0017118.g003
Figure 2. Subunit c deposits co-localize with Lamp 1 in homozygous CbCln3
Dex7/8 and CbCln6
nclf cells. A. Representative micrographs of
confluency aged wild-type, CbCln3
Dex7/8/Dex7/8 and CbCln6
nclf/nclf cells, co-immunostained with antibodies recognizing subunit c (green) and the
mitochondrial marker, grp75 (red). Note the large accumulations of subunit c immunostain (white arrows) in both CbCln3
Dex7/8/Dex7/8 and CbCln6
nclf/
nclf cells, but which are not common in the wild-type cells. Moderate overlap of the subunit c and grp75 immunostains is observed in wild-type cells
(yellow in overlay), but little to no overlap is seen in CbCln3
Dex7/8/Dex7/8 and CbCln6
nclf/nclf cells. Also, again note the elongated mitochondrial
morphology revealed by the grp75 immunostain in CbCln3
Dex7/8/Dex7/8 and CbCln6
nclf/nclf cells, compared to wild-type cells. B. Representative
micrographs of confluency aged wild-type, CbCln3
Dex7/8/Dex7/8, and CbCln6
nclf/nclf cells, co-immunostained with antibodies recognizing subunit c
(green) and Lamp 1 (red). Limited overlap of subunit c and Lamp 1 immunostain is observed in wild-type cells (yellow in overlay), but Lamp 1
strongly, though not perfectly, overlaps with the accumulated subunit c in CbCln3
Dex7/8/Dex7/8 and CbCln6
nclf/nclf cells. Note that in confluency aged
cultures, the Lamp 1-labeled compartment appears expanded and/or aggregated in the mutant cells, which was not observed under sub-confluent
culture conditions (not shown). A,B. Insets provide a zoomed view of the degree of immunostain overlap (yellow). Blue=DAPI stain. Images were
captured with a 40X objective and, for like stains, were taken on the same day with identical settings.
doi:10.1371/journal.pone.0017118.g002
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between them, reflecting common pathways that were changed in
the opposite direction in CbCln6
nclf/nclf and CbCln3
Dex7/8/Dex7/8
cells (Figure S4).
Intriguingly,consistent withbiological datasupporting alysosomal
localization and function for the Cln3-encoded protein, lysosomal
function-related (GO:0005773, GO:0000323, GO:0005764) gene
sets were among the top 20 in the homozygous CbCln3
Dex7/8 list, but
not in the homozygous CbCln6
nclf gene set list (Table 2). Conversely,
consistent with the ER localization of the Cln6-encoded protein, ER-
function (GO:0005783), protein biosynthesis (GO:0009059,
GO:0006412) and protein transport-related (GO:0015031,
GO:0045184, GO:0008104) gene sets were among the top 20 in
the homozygous CbCln6
nclf list (Table 3), but were ranked
substantially lower in the homozygous CbCln3
Dex7/8 gene set list.
Thus, our unbiased global gene expression analysis of
CbCln3
Dex7/8 and CbCln6
nclf cerebellar cells lends further support
for the hypothesis that Cln3 and Cln6 mutations initiate disease via
distinct molecular and cell biological processes that converge on a
common pathway. Moreover, a number of potentially relevant
pathways have been identified, including oxidative phosphoryla-
tion, that merit further investigation into their role in the NCL
disease process.
Discussion
The NCLs, while genetically heterogeneous, share a common
pathological feature, the accumulation and storage of ceroid
lipofuscin, which appears to mostly be comprised of dolichol lipids
and the hydrophobic protein, subunit c of mitochochondrial ATP
Figure 4. Altered fluid-phase endocytosis and LysoTrackerH stain in homozygous CbCln3
Dex7/8 and CbCln6
nclf cells. A. Representative
micrographs of CbCln3 cells (wild-type and homozygous) and CbCln6 (wild-type and homozygous) cells stained with the fluid-phase endocytic
marker, dextran Alexa-488 (green), and the lysosomal marker, LysoTrackerH-Red (red), are shown. Reduced vesicular staining is evident in the
homozygous cells, compared to wild-type cells for both CbCln3 and CbCln6 cells. However, note the differential distribution pattern of the labeled
vesicles in homozygous CbCln3
Dex7/8 cells, compared to homozygous CbCln6
nclf cells. Labeled vesicles in homozygous CbCln6
nclf cells remain
perinuclear localized, as they appear in wild-type cell lines. To the contrary, labeled vesicles in homozygous CbCln3
Dex7/8 cells appear less perinuclear
localized, compared to wild-type cells and homozygous CbCln6
nclf cells. All images were captured at 406magnification and were taken on the same
day with identical settings. B. Bar graphs depicting quantification of labeled endosomes (left) and lysosomes (right) in CbCln3 cells (CbCln3
+/+ and
CbCln3
Dex7/8/Dex7/8) and CbCln6 (CbCln6
+/+ and CbCln6
nclf/nclf) cells are shown. Mean vesicle count/cell was significantly reduced (*p,.001) in both
homozygous CbCln3
Dex7/8and CbCln6
nclf cells, compared to the respective wild-type or heterozygous cell lines. A student’s t-test also revealed a
significant difference (p,.001) between the homozygous cell lines of differing genotype (i.e. CbCln3
Dex7/8/Dex7/8 versus CbCln6
nclf/nclf), which was
suggestive of a more dramatic reduction of stained vesicles in the CbCln3
Dex7/8/Dex7/8 cells.
doi:10.1371/journal.pone.0017118.g004
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CbCln6
nclf cerebellar cells, like homozygous CbCln3
Dex7/8 cere-
bellar cells, can be induced to accumulate mitochondrial ATP
synthase subunit c in Lamp-1 positive compartments by aging in
confluent culture conditions. The results of our comparative
analyses in sub-confluent cultured homozygous CbCln6
nclf and
CbCln3
Dex7/8 cerebellar cells have distinguished the underlying
biological and molecular processes that presage this shared overt
disease-associated storage of subunit c. Moreover, the divergent
early processes uncovered here strongly support the hypothesis
that the CLN6 and CLN3-encoded proteins serve distinct functions
in neuronal cells.
Indeed, consistent with the predominant ER localization of
CLN6p, the vLINCL mutation appears to significantly impact the
ER, strongly implicating CLN6p in the proper function of this
important membrane organelle. For example, PDI immunostain
was specifically decreased in homozygous CbCln6
nclf cells and
patient lymphoblasts, suggesting altered disposition of this protein-
folding chaperone, and the expression of ER-related gene sets
were among the highest ranked in homozygous CbCln6
nclf cells,
suggesting that CLN6p is required for ER function and protein
biosynthesis, perhaps of endosomal-lysosomal proteins given the
clear impact of the loss of CLN6p function on endocytosis and
lysosomal turnover of the subunit c protein. Why PDI immuno-
stain was altered in the homozygous CbCln6
nclf cells remains
unclear, but the lack of a concomitant significant change in BiP
suggested that these cells were not undergoing a global unfolded
protein response. Further study of the PDI phenotype is needed to
shed new light on the specific ER-associated pathways connected
to CLN6p dysfunction. It was also intriguing that our pathways
analysis here specifically highlighted gene expression changes in
membrane-associated receptor proteins in the homozygous
CbCln6
nclf cells, which is suggestive of a role for CLN6p in the
regulation of this protein family.
Similarly, consistent with the primary localization of CLN3p
within the endosomal-lysosomal system, ER biology was not
dramatically altered by the JNCL mutation but instead the results
of our pathways analysis implied that lysosomal biology was
strongly affected in the homozygous CbCln3
Dex7/8 cerebellar cells,
which was consistent with biological data in this study and others
(reviewed in [9]). Moreover, relatively specific changes in gene sets
related to metabolic processes, such as fatty acid and amino acid
metabolism, and in ion transport in CbCln3
Dex7/8 cerebellar cells,
which were not evidently dramatically changed in homozygous
CbCln6
nclf cells, suggests focusing studies aimed at CLN3p
function on these processes.
It is noteworthy that homozygous mutation of Cln3 or Cln6 in
our cerebellar cell models of JNCL and vLINCL did not
dramatically alter expression at the other NCL loci, at least by
Affymetrix array analysis, supporting distinct primary functions for
the differing NCL related proteins, consistent with the observation
that NCL patients have varied storage material ultrastructure, age-
at-onset, and order of symptom onset that typically correlates with
the genetic etiology [13,14]. However, subtler gene expression
changes in the other NCL loci were detected, in particular, in
follow-up analysis by the more sensitive method of qRT-PCR,
supporting the hypothesis that the NCL gene functions converge
on a common pathway.
Biological areas that merit further investigation, because they
were commonly altered in cerebellar cells in response to CLN6p
and CLN3p dysfunction, are aspects of vesicle/membrane
trafficking, protein transport, and altered metabolism. For
example, future study of alterations in Snf8 and Fscn1, which were
two of the validated gene changes in homozygous CbCln6
nclf and
CbCln3
Dex7/8 cells (Table 1, Table S3), could lead to an improved
understanding of the altered trafficking in these two forms of NCL.
Snf8 (a.k.a. ESCRT-II complex subunit VPS22), which is involved
in sorting endocytosed and ubiquitinated proteins into multivesic-
ular bodies for subsequent lysosomal delivery and degradation
[43], was significantly upregulated in homozygous CbCln3
Dex7/8
cells, and significantly downregulated in homozygous CbCln6
nclf
cells (Tables 1 and S3). Fscn1 (fascin-1), an actin-bundling protein
highly expressed in brain (reviewed in [44]), was downregulated in
both homozygous CbCln3
Dex7/8 and homozygous CbCln6
nclf cells
(Tables 1 and S3). The importance of the actin cytoskeleton in
membrane trafficking is well documented (reviewed in [45]), and a
role for CLN3p in membrane-cytoskeletal interactions has already
been proposed [46,47].
It is reasonable to postulate that the commonly altered
molecular genes and pathways in homozygous CbCln6
nclf and
CbCln3
Dex7/8 cells may culminate in the abnormal accumulation
of mitochondrial ATP synthase, subunit c protein that becomes
manifest when homozygous CbCln6
nclf and CbCln3
Dex7/8 cells are
stressed by aging at confluent cell density. Our co-staining analyses
of the formed deposits was suggestive that in both homozygous
CbCln6
nclf and CbCln3
Dex7/8 cells, the accumulation of the subunit
c protein occurs within acidic organelles rather than in the
mitochondrion itself, consistent with a defect in the autophago-
Figure 5. Venn diagram depicting degree of overlap in gene
expression changes in homozygous CbCln3
Dex7/8 and CbCln6
nclf
cells. 981 probes were significantly changed in CbCln3
Dex7/8/Dex7/8 cells,
compared to CbCln3
+/+ cells (red). 718 probes were significantly
changed in CbCln6
nclf/nclf cells, compared to CbCln6
+/+ cells (blue). A
61.4-fold change and p#0.01 cut-off was applied to generate these
datasets. As represented by the pie chart, among the 36 shared probes,
8 (22%) were concordant in their direction of change in the
CbCln3
Dex7/8/Dex7/8 and CbCln6
nclf/nclf cells, while 28 (78%) were
discordant in their direction of change in the CbCln3
Dex7/8/Dex7/8 and
CbCln6
nclf/nclf cells.
doi:10.1371/journal.pone.0017118.g005
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subunit c-positive foci that formed in the homozygous CbCln6
nclf
and CbCln3
Dex7/8 cells were morphologically heterogeneous, so,
while dramatic differences were not apparent, it would also be
worthwhile to determine whether the vLINCL and JNCL
mutations may give rise to subtle differences in the relative
kinetics and features of subunit c turnover.
In summary, our data are consistent with distinct functions for
the CLN3p and CLN6p proteins, that likely primarily work in
distinct processes regulating shared downstream biological path-
ways that are connected to the lysosome, the mitochondrion and
subunit c turnover, in a manner that is essential for proper
neuronal cell survival. Our findings, therefore, support the
interconnected goals of developing therapeutics based on a full
understanding of CLN3p and CLN6p functions, which may prove
to be disease-specific, as well as therapeutics aimed at circum-
venting or preventing the changes proximal to the overall
dysfunction of cellular energetics and membrane function that
result in storage of ceroid lipofuscin and neuronal cell death.
Materials and Methods
Ethics Statement
All mouse protocols were in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals and were reviewed and approved by the Massachusetts
Table 1. Significant probes shared between CbCln6
nclf and CbCln3
Dex7/8datasets.
Probe Gene Symbol CbCln6
nclf/nclf Cells Fold Change CbCln3
Dex7/8/Dex7/8 Cells Fold Change
1417505_s_at Il11ra1 243.6 30.3
1418675_at Osmr 223.6 20.6
1459888_at LOC545261 214.5 13.5
1447975_at LOC545261 25.7 5.0
1433653_at BC029169 211.3 8.9
1437760_at Galnt12 27.3 12.7
1416516_at Fscn1 24.7* 21.9*
1448378_at Fscn1 22.9* 22.0*
1448901_at Cpxm1 23.2 5.1
1455604_at Fzd5 23.1 22.6
1419664_at Srr 22.7 2.7
1435830_a_at 5430435G22Rik 22.4 2.7
1426306_a_at Maged2 22.3 4.4
1436033_at BC031353 22.1 3.3
1452034_at Prepl 21.8 21.7
1432526_a_at Snf8 21.8* 1.6*
1433668_at Pnrc1 21.7 2.1
1448343_a_at Nbr1 21.7 2.0
1436795_at 9630058J23Rik 21.6 21.6
1415776_at Aldh3a2 21.6 1.6
1452094_at P4ha1 21.5 21.5
1421139_a_at Zfp386 1.5 21.7
1434724_at Usp31 1.6 22.6
1416004_at Ywhah 1.7 21.6
1423682_a_at Cdca4 1.9 21.8
1417024_at Hars 2.0 21.6
1435467_at Fgd6 2.0 22.4
1424675_at Slc39a6 2.2 21.6
1455321_at Ddhd1 2.2 2.2
1421103_at Bmp2k 2.2 27.0
1455829_at Usp14 2.4 21.6
1416208_at Usp14 2.4 21.5
1451818_at Mib1 2.7 21.6
1423735_a_at Wdr36 2.7 21.5
1459885_s_at Cox7c 3.6 22.9
1457632_s_at Meis2 4.0 1.6
*Validated by qRT-PCR.
doi:10.1371/journal.pone.0017118.t001
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(SRAC), which serves as the Institutional Animal Care and Use
Committee (IACUC) for MGH (Protocol #2005N000289).
The use of anonymous, de-identified human patient lympho-
blast cell lines for our NCL research was reviewed by the Partners
Institutional Review Board and deemed exempt (2010P-001489).
Animals
Cln6
nclf spontaneous mutant mice were originally purchased
from The Jackson Laboratory, and were subsequently maintained
as a breeding colony on the C57Bl6/J background, at Massachu-
setts General Hospital. Genotypes were determined by the mouse
nclf exon 4 insertion assay, from tail biopsy DNA, as previously
described [28]. Cln3
Dex7/8 mutant mice were previously described
[32].
Antibodies and Cell Staining Reagents
Commercial antibodies used were anti-nestin (Rat 401, Devel-
opmental Studies Hybridoma Bank, maintained by The University
of Iowa, Department of Biological Sciences), anti-GFAP
(cat#Z0334, Dako Corporation), anti-PDI (H-160, cat#sc-20132,
Santa Cruz Biotechnology), anti-GM130 (cat#G65120, BD
TransductionLaboratories),anti-tubulin(Sigma), anti-BiP(Abcam),
anti-EEA1 (C-15, cat#sc-6414, Santa Cruz Biotechnology), anti-
Rab7 (C-19, cat#sc-6563, Santa Cruz Biotechnology), anti-Lamp 1
(1D4B, cat#sc-19992, Santa Cruz Biotechnology), anti-Grp75
(cat#SPS-825, Stressgen). All fluorescent secondary antibodies used
were obtained from Molecular Probes/Invitrogen and were used at
a 1:200 dilution. Cell staining reagents used were LysoTrackerH
Red DND-99 (500 nM; cat#L-7528, Invitrogen) and 10,000 MW
dextran-Alexa FluorH 488 (1 mg/ml; cat#D-22910, Invitrogen).
A new subunit c antibody was generated to replace the
diminishing stocks of the previously described subunit c antibody
generated by Dr. Kominami [20,32,50]. A peptide corresponding
to amino acids 62–73 of the subunit c protein (the N-terminus of
the mature protein) was synthesized with an additional C-terminal
cysteine residue for carrier protein conjugation by the MGH
Peptide Core Facility. Keyhole limpet hemocyanin (KLH)-
conjugated peptide was used for rabbit immunization, and antisera
were collected and affinity purified according to standard
procedures (Quality Controlled Biochemicals). The new anti-
subunit c antibody was tested alongside the previously described
subunit c antibody [20,32,50] and was found to perform similarly
in all immunostaining and immunoblot assays (data not shown).
All subunit c data contained herein were obtained with the new
subunit c antibody, used at 1:200–1:500 dilution.
Generation and maintenance of CbCln6
nclf and
CbCln3
Dex7/8 cerebellar neuronal precursor cell lines
CbCln6
nclf cerebellar neuronal precursor cell lines were
established in the same manner as CbCln3
Dex7/8 cerebellar
neuronal precursor cells, which were previously described [20].
Table 2. 20 highest-ranked gene sets significantly altered in CbCln3
Dex7/8/Dex7/8 cerebellar cells.
CbCln3
Dex7/8Dex7/8 Cells Dataset CbCln6
nclf/nclf Cells Dataset
Pathway NTk Rank
* NTk Stat NTk Rank NTk Stat
KEGG:Oxidative_phosphorylation 1.0 12.3 17.3 210.2
GO:0015078 hydrogen ion transporter activity 2.0 11.4 23.0 28.9
GO:0015077 monovalent inorganic cation transporter activity 3.3 11.0 24.3 28.8
KEGG:Fatty_acid_metabolism 4.0 10.9 354.2 22.9
GO:0003954; GO:0050136; GO:0008137; GO:0015081 NADH
dehydrogenase activity
5.3 10.9 192.7 23.5
KEGG:Porphyrin_and_chlorophyll_metabolism 5.3 10.8 271.5 23.1
GO:0016655 oxidoreductase activity, acting on NADH or NADPH,
quinone or similar compound as acceptor
7.0 10.6 149.2 24.7
KEGG:Valine,_leucine_and_isoleucine_degradation 8.0 10.1 427.8 22.8
GO:0015399 primary active transporter activity 9.0 10.1 32.0 28.2
GO:0016667 oxidoreductase activity, acting on sulfur group of donors 10.3 29.7 892.2 21.9
GO:0015036 disulfide oxidoreductase activity 10.7 29.6 1268.0 21.1
KEGG:Ribosome 12.0 8.9 27.0 28.7
GO:0006119 oxidative phosphorylation 13.0 8.8 182.0 23.6
GO:0046873 metal ion transporter activity 14.0 8.7 86.5 26.0
GO:0042773 ATP synthesis coupled electron transport 15.0 8.4 246.2 23.2
GO:0005773 vacuole 16.0 8.0 172.2 23.7
GO:0000323; lytic vacuole GO:0005764; lysosome 17.7 7.9 220.8 23.3
GO:0016491 oxidoreductase activity 18.0 7.8 52.0 26.8
GO:0019370 leukotriene biosynthesis 18.3 27.8 1220.3 1.2
GO:0006691 leukotriene metabolism 21.3 27.5 1157.3 1.4
*The top 20 NTk ranked gene set pathways in the CbCln3
Dex7/8 dataset are shown (NTk Rank), ranked by the sigPathway program according to the average NTk statistics
(NTk Stat). NTk statistics reflect how significant changes were within a given gene set (the higher the absolute value of the statistic, the greater its significance), and the
direction of change (indicated by positive or negative statistics). For comparison, the CbCln6
nclf dataset NTk Rank and NTk Stat values are also shown. Replicated gene
sets were grouped together. For example, four different gene sets, categorized ‘NADH dehydrogenase activity’, gave identical statistics, so they are grouped together
into one row of the table, with the individual gene set identifiers listed in the ‘Pathway’ column.
doi:10.1371/journal.pone.0017118.t002
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type, heterozygous, and homozygous Cln6
nclf (or Cln3
Dex7/8)
littermate mice, and primary cultures were established that were
enriched for cerebellar granule neurons, according to previously
established procedures [51]. Cultures were then transduced with a
retroviral vector containing the tsA58/U19 temperature-sensitive
SV40 large T antigen and a neomycin selection marker [52].
Clones were selected for growth in 400 mg/ml G418, and multiple
clonal cell lines were isolated for each genotype that expressed the
neural stem cell marker, nestin, but lacked glial fibrillary acidic
protein (GFAP) expression by immunofluorescence and, in some
cases, also confirmed by Western blot, to verify a neuronal lineage
(Figure S1 and [20]). Once established, cell lines were re-
genotyped using previously described Cln6
nclf and Cln3
Dex7/8
genotyping assays [20,28]. The expression and endoplasmic
reticular-localization of the CLN6p protein was confirmed in the
wild-type cells, and significantly reduced expression was observed
in the homozygous CbCln6
nclf cells, consistent with previous
reports [31,53] (data not shown).
For maintenance, CbCln6
nclf and CbCln3
Dex7/8 cerebellar
neuronal precursor cells were grown between 30 and 90%
confluency on plastic tissue culture dishes in ‘Cbc’ media
(Dulbecco’s Modified Eagle Medium [DMEM; Gibco BRL
#11995-065], 10% heat-inactivated fetal bovine serum [FBS;
Sigma #12306C], 24 mM KCl, penicillin/streptomycin/gluta-
mine [1X, Gibco BRL], and G418 [200 mg/ml] to maintain
selection), in a water-jacketed, humidified incubator maintained at
33uC, 5% CO2 atmosphere. Passage number was recorded and
cells were used for experiments up to ,passage 15, without
apparent impact on phenotypes. All phenotypes were tested in 2–3
independent cell lines per genotype to ensure they represented a
genotype-phenotype relationship, rather than just inter-subclone
variability. Except where noted, data shown were from represen-
tative cell lines. Mycoplasma testing was routinely carried out
using the MycoAlert Mycoplasma Detection Kit (Lonza #LT07-
118), according to the manufacturer’s recommendations, to ensure
no mycoplasma contamination of cell culture.
Lymphoblast cell culture
Patient lymphoblast cell lines were previously collected [28] and
were grown as previously described [54]. The CLN6 patient
lymphoblast line was from a male with Costa Rican ancestry
harboring a homozygous mutation in exon 3 (c.214G.T,
p.Glu72X) that predicts a prematurely truncated protein product
[28].
Immunostaining
For immunostaining of cultured cells and subsequent confocal
microscopy, cells were seeded onto 18 mm diameter glass No. 1
coverslips (Fisher Scientific), inside a 12-well tissue culture petri
dish, at a density of ,4610
4 cells/well, and cells were grown
overnight in Cbc media, at 33uC, 5% CO2. The following day,
coverslips were fixed inside the well with either ice-cold 4%
formaldehyde/PBS, pH 7.4, incubated for 209 at room temper-
ature, or with ice-cold methanol:acetone (1:1), for 109 at 220uC,
following by air drying, depending on the antibody. Following
Table 3. 20 highest-ranked gene sets significantly altered in CbCln6
nclf/nclf cerebellar cells.
CbCln6
nclf/nclf Cells Dataset CbCln3
Dex7/8/Dex7/8 Cells Dataset
Pathway NTk Rank* NTk Stat NTk Rank NTk Stat
GO:0001584 rhodopsin-like receptor activity 1.0 12.5 1044.0 21.1
GO:0004930 G-protein coupled receptor activity 2.0 12.3 1474.7 20.6
GO:0005783 endoplasmic reticulum 3.0 212.1 46.7 5.0
GO:0009059 macromolecule biosynthesis 4.0 211.8 732.2 1.6
GO:0006412 protein biosynthesis 5.0 211.6 846.5 1.4
GO:0004888 transmembrane receptor activity 6.0 11.5 423.5 2.4
GO:0015031 protein transport 7.3 211.1 53.0 4.5
KEGG: Neuroactive_ligand-receptor_interaction 8.0 11.1 612.2 21.9
GO:0045184 establishment of protein localization 9.3 211.0 54.7 4.5
GO:0015268 alpha-type channel activity 10.3 10.9 1624.0 20.4
GO:0008104 protein localization 11.0 210.8 51.3 4.6
GO:0031090 organelle membrane 11.0 210.9 34.0 6.0
GO:0015267 channel or pore class transporter activity 13.3 10.6 839.5 21.4
GO:0007186 G-protein coupled receptor protein signaling pathway 13.7 10.6 413.0 22.4
GO:0005216 ion channel activity 15.0 10.4 1395.0 20.6
GO:0005840 ribosome 16.0 210.3 26.3 6.9
KEGG: Oxidative_phosphorylation 17.3 210.2 1.0 12.3
GO:0003735 structural constituent of ribosome 17.7 210.2 24.0 7.0
GO:0030529 ribonucleoprotein complex 19.0 29.8 442.5 2.4
GO:0042165 neurotransmitter binding 20.0 9.6 768.3 21.6
*The top 20 NTk ranked gene set pathways in the CbCln6
nclf/nclf dataset are shown (NTk Rank), ranked by the sigPathway program according to the average NTk
statistics (NTk Stat). NTk statistics reflect how significant changes were within a given gene set (the higher the absolute value of the statistic, the greater its significance),
and the direction of change (indicated by positive or negative statistics). For comparison, the CbCln3
Dex7/8 dataset NTk Rank and NTk Stat values are also shown.
doi:10.1371/journal.pone.0017118.t003
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culture dish, and processed for immunostaining, as previously
described [20]. For buffer incubations, coverslips, set atop parafilm
inside a large Petri dish, were overlaid with 100–300 ml of the
appropriate solution, and aspiration from the coverslip edge was
used to remove previous buffers. Following immunostaining,
coverslips were mounted onto slides with ProLongH Gold antifade
reagent with or without DAPI (Invitrogen), according to the
manufacturer’s recommendations. Nail polish-sealed coverslips
were imaged on a Leica SP5 AOBS scanning laser confocal
microscope (Leica Microsystems). Like-stained wild-type and
homozygous mutant samples were mounted on the same
microscope slide and were imaged in the same session, with
identical settings.
LysoTrackerH and Endocytosis Assay
LysoTrackerH staining and 10,000 molecular weight dextran-
Alexa FluorH 488 endocytic uptake was as previously described
[32], but was adapted to a 96-well, high-content imaging format.
Cerebellar cells were seeded into clear-bottomed, 96-well CostarH
tissue culture plates (Corning Inc.) at a density of 5000 cells/well
(100 ml volume). Following overnight incubation at 33uC, in a 5%
CO2 humidified tissue culture incubator, the media was aspirated
and exchanged for pre-warmed, fresh media containing 500 nM
LysoTrackerH DND-99 and 1 mg/ml dextran-Alexa FluorH 488,
using a multipipettor. Plates were immediately placed back in the
tissue culture incubator. Following 309 incubation, plates were
fixed with ice-cold 4% formaldehyde in PBS, pH 7.4 on ice, for
209. Wells were then rinsed with PBS, pH 7.4 five times, 109 each.
Following aspiration of the final PBS rinse, nuclei were
counterstained with Hoechst dye for 5 minutes and rinsed twice
in PBS, pH 7.4. Finally, 100 ml of PBS, pH 7.4 plus 0.5% sodium
azide was added and plates were sealed and stored at 4uC. Plates
were imaged on an ImagXpress Micro automated high-content
imaging system (Molecular Devices), set to capture 3 sites per well,
at 106 magnification. The Transfluor module of MetaXpress
software (Molecular Devices) was used to determine the ‘mean
vesicle count per cell’ from captured images. Images were
segmented into nuclei and stained vesicle compartments using
the ‘vesicles’ parameter in the Transfluor module. The ‘mean
vesicle count per cell’ was determined from all nuclei captured in 3
images/well, and from 8 or more replicate wells per cell line.
Poorly focused images were excluded from analysis. Red
(LysoTrackerH) and green (dextran-Alexa FluorH 488) channels
were analyzed separately. Significance was determined using a
Student’s T-test.
Quantification of mitochondrial shape
Images of grp75 immunostained cells were collected on the
same day with the same settings, and were then analyzed to
quantify mitochondrial shape using ImageJ software (v1.44k for
Macintosh; http://rsbweb.nih.gov/ij/). Images were first thre-
sholded in ImageJ, then the ‘analyze particles’ function was used to
segment and measure the mitochondrial circularity. A circularity
index of ‘1’ indicates a perfect circle. At least 3 independent,
random fields per coverslip, representing a total of ,100–150 cells
per line, were analyzed.
Gene expression analysis
Gene expression experiments were carried out through the NIH
Neuroscience Microarray Consortium, within the UCLA Center.
Total RNA from three different cell lines per genotype was
isolated at MGH using TRIzol reagent (Invitrogen), according to
the manufacturer’s recommendations. Prepared RNA samples
were submitted to the UCLA DNA Microarray Facility (micro-
array.genetics.ucla.edu) for cDNA preparation and hybridization.
All RNA samples passed quality checks on the Nanodrop (Thermo
Scientific) and Agilent Bioanalyzer (Agilent Technologies). cDNA
was prepared and hybridized to MOE 430 2.0 Affymetrix
GeneChipH oligonucleotide microarrays, according to standard
protocols at the UCLA Facility. Microarray data were corrected
for backgrounds and normalized using gcRMA (R, 2.6.2; Biobase,
1.16.3; gcrma, 2.10.0).
The microarray data are MIAME compliant, and the raw data have
been deposited in NCBI’s Gene Expression Omnibus [55] and are
accessible through GEO Series accession number GSE24368 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24368).
Real-time qRT-PCR was performed to validate selected genes
in the homozygous CbCln3
Dex7/8 and CbCln6
nclf cell lines,
according to standard procedures, using Gapdh and/or b-actin
(Actb) as unchanged housekeeping gene controls (see Table S8 for
specific primer information). From the same original total RNAs
used for the array experiments, cDNA was generated from 1 mg
RNA using SuperScript II reverse transcriptase (Invitrogen). Real-
time PCR was performed using SYBR Green (Roche) according to
the manufacturer’s instructions and analyzed on a LightCycler 480
instrument (Roche) using the following thermocycling conditions:
an initial denaturation step of 95uC for 5 minutes followed by 45
cycles of 95uC for 10 seconds, 56uC for 10 seconds, and 72uC for
10 seconds.
The DAVID Bioinformatics Resource 6.7 [56,57] was used for
further gene ontology analysis of significant probes.
For identification of significantly enriched pathways, we used
sigPathway (1.6.0) (http://bioconductor.org/packages/release/
bioc/html/sigPathway.html) [41]. Following analysis using sig-
Pathway software, ‘NEk statistics’ and ‘NTk statistics’ were output
as measures of how significant changes were for a given gene set
(the higher the absolute value of the statistic, the greater its
significance), and the direction of change (indicated by positive or
negative statistics). ‘NEk statistics’ represented enrichment statistics
based on phenotype permutations, and ‘NTk statistics’ represented
gene set permutation-based test results (60,000 permutations). A
false discovery rate cut-off of less than 0.01 was applied for both
NTk and NEk statistics for each gene set, within a given genotype
comparison (e.g. CbCln6
nclf/nclf versus CbCln6
+/+ and
CbCln3
Dex7/8/Dex7/8 versus CbCln3
+/+), and the total list of
significantly changed gene sets (FDR,.01) are supplied in Tables
S1 and S2. We considered the NTk statistics to have a greater
reliability than the NEk statistics, given a limited number of
unique permutations to construct a null distribution of test
statistics. Therefore, in the summary tables presented in Tables 2
and 3, only the NTk values are shown. Both NTk and NEk values
are shown in the supporting information tables (Tables S6 and S7).
Subunit c accumulation assay
The subunit c accumulation assay was modified from that which
has been previously described [20]. Cells were seeded onto
100 mm petri dishes at a density of 2610
5 cells/plate and
subsequently incubated at 33uC, 5% CO2 for between seven and
ten days. Separate plates for each cell line were maintained at sub-
confluent density, as described above, for use as un-aged controls,
which do not show significant subunit c accumulations in this
assay.
For immunostaining, confluency aged or un-aged control cells
were trypsinized and replated onto 18 mm No. 1 glass coverslips
inside a 12-well tissue culture plate at a density of 8610
4 cells/
well. Replated cells were then incubated overnight at 33uC, 5%
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ing, which were carried out as described above.
ATP assay
Un-aged control and mutant cells were trypsinized and replated
into clear-bottomed, 96-well CostarH tissue culture plates (Corning
Inc.) at a density of 10, 000 cells/well (100 ml volume). Total
cellular ATP levels were assayed using the CellTiter-GLOH
Luminescent Cell Viability kit (Promega), according to the
manufacturer’s recommendations and as previously described
[20]. Experiments conducted on the set of CbCln3 cell lines (i.e.
wild-type, heterozygous, and homozygous lines) were performed at
the same time, and those on CbCln6 cell lines were performed at
the same time, but independently from the CbCln3 cell lines. To
enable comparison across experiments, absolute RLUs were
normalized to the respective wild-type numbers.
Supporting Information
Figure S1 Marker immunostaining of CbCln6
nclf cere-
bellar neuronal precursor cells. Representative micrographs
of nestin- (green) and GFAP-(red) immunostained wild-type
(CbCln6
+/+), heterozygous (CbCln6
+/nclf), and homozygous
(CbCln6
nclf/nclf) neuronal precursor cell lines are shown. Selected
clones were further confirmed as positive or negative for the
markers by immunoblot analysis (not shown). 206magnification.
(TIF)
Figure S2 Quality control of the CbCln3
Dex7/8 and
CbCln6
nclf cell gene expression datasets using principal
components analysis (PCA). PCA plots for CbCln6
nclf cells
(top row, red circles) and CbCln3
Dex7/8 cells (bottom row, blue
circles) are shown. In all plots, closed circles represent data from
mutant cells and open circles represent data from wild-type cells.
As expected, PCA plots for the entire gcrma-normalized datasets
(‘Total Probes’) show good separation by genotype, but also some
variation among biological replicates, which most likely arose from
the original derivation of the cell lines, which were from different
mouse pups of the same genotype. The use of biological replicates
from independent animals for our gene expression study was
desirable in order to achieve our goal of capturing the gene
expression variation that was a consequence of the genetic
mutation. To further explore the variation in our datasets, we
performed additional PCA analyses on the most variable probes
(‘Top 1000 Variable Probes’), the most variable significant probes
(‘Significant Probes’), and the most variable non-significant probes
(‘Non-significant Probes’). The PCA plots for the ‘Top 1000
Variable Probes’ were highly similar to the ‘Total Probes’ PCA
plots, demonstrating that restricting our analysis to a smaller set of
probes did not dramatically alter the variation structure among the
samples. However, PCA analysis of the top significant probes for
each comparison (106 probes in CbCln6
+/+ versus CbCln6
nclf/nclf
cells, and 110 probes in CbCln3
+/+ versus CbCln3
Dex7/8/Dex7/8
cells) showed good separation by genotype, and the biological
replicates were tightly overlapping on PC1. Conversely, the top
non-significant probes did not produce strong separation by
genotype or biological replicate in the PCA plots (for consistency,
the quantity of probes used was kept the same as for the signficant
probes analysis). Therefore, these data suggested that PC1 in the
PCA using all probes (‘Total Probes’) captured genotype-
correlated variance, and that non-genotype-correlated variance
(i.e. PC2) was effectively removed in our significantly altered
probes.
(TIF)
Figure S3 PCA analysis of significant probes across the
CbCln3
Dex7/8 and CbCln6
nclf cell datasets. PCA plots for
CbCln6
nclf cells (top row) and CbCln3
Dex7/8 cells (bottom row) are
shown, representing significant probes (left graphs), and significant
probes from the opposing NCL genotype datasets (right graphs).
For relevant comparisons of plots, we used the same scale for each
genotype. Note that the significant probes (p,.01, fold-
change.1.5) from the CbCln6
nclf cells dataset, plotted for wild-
type CbCln6
+/+ (open red circles) and homozygous mutant
CbCln6
nclf cells (closed red circles), clearly separated the wild-type
and mutant genotypes, and that the biological replicates were
strongly overlapping (top left panel). The same was true of
the significant probes (p,.01, fold-change.1.5) from the
CbCln3
Dex7/8 cells dataset, plotted for wild-type (open blue circles)
and homozygous mutant (closed blue circles) CbCln3
Dex7/8 cells
(bottom left panel). To the contrary, the significant probes from
the unrelated genotype dataset, plotted for wild-type (open circles)
and homozygous mutant (closed circles) cells, did not strongly
distinguish the wild-type from mutant for either the CbCln6
nclf
cells (top right) or the CbCln3
Dex7/8 cells (bottom right).
(TIF)
Figure S4 Scatterplot analysis of NTk Statistics for
CbCln3
Dex7/8 and CbCln6
nclf significant pathways. Scat-
terplots of CbCln3
Dex7/8 versus CbCln6
nclf NTk statistics (NTk Stat)
are shown for the significant pathways from the CbCln3
Dex7/8
dataset (left), and for the significant pathways from the CbCln6
nclf
dataset,identified bythesigPathway program.Therewasa negative
correlation between the significant pathways identified in the
homozygous CbCln3
Dex7/8 and CbCln6
nclf cells (Pearson correlation
coefficients and significance values are shown), suggesting some
overlap in the pathways affected by the Cln3
Dex7/8 and Cln6
nclf
mutations, but that the direction of change in the pathways was
typically different.
(TIF)
Table S1 Significant probes in the CbCln3
Dex7/8 dataset.
The Affymetrix probes (Probe ID), with significant (p,0.01, Student’s
t-test) expression level differences in the CbCln3
Dex7/8/Dex7/8 cells,
versus the CbCln3
+/+ cells are shown, along with the corresponding
gene symbols and titles. Mean expression values were determined
across three biological replicates per genotype, and the standard
deviation (SD) for the replicates is shown. Log2 fold-change (‘Fold
Change’) is also shown. A cut-off was applied of greater than 1.5-fold
change, to arrive at the list of significant probes.
(XLS)
Table S2 Significant probes in the CbCln6
nclf dataset. The
Affymetrix probes (Probe ID), with significant (p,0.01, Student’s t-
test) expression level differences in the CbCln6
nclf/nclf cells, versus the
CbCln6
+/+ cells are shown, along with the corresponding gene
symbols and titles. Mean expression values were determined across
three biological replicates per genotype, and the standard deviation
(SD) for the replicates is shown. Log2 fold-change (‘Fold Change’) is
also shown. A cut-off was applied of greater than 1.5-fold change, to
arrive at the list of significant probes.
(XLS)
Table S3 qRT-PCR to validate the relative expression of
selected genes in CbCln6
nclf and CbCln3
Dex7/8 cells. Gene
expression levels were normalized to Gapdh or Actb housekeeping
gene expression levels. Representative means measured across at
least triplicate qRT-PCR reactions are shown. P-values to
determine the significance of the expression level differences in
wild-type versus mutant cells were calculated using a student’s t-test.
Primers used are shown in Table S8. n.d.=not determined. Tagln2
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because this gene change was only identified in the CbCln6 dataset.
(XLS)
Table S4 DAVID gene ontology analysis of significant
CbCln3
Dex7/8 probes. The significantly enriched (p,0.01) gene
ontology terms (GOTERM/Term) from the Biological Process
and Cellular Component categories are shown, determined
through analysis of the significant CbCln3
Dex7/8/Dex7/8 probes in
DAVID Bioinformatics Resources 6.7. The number of probes (and
the % of the total) that were represented by the GO term (Probe
Count) is indicated, and the Probe-IDs are listed (Probes). The
relative enrichment value (Fold Enrichment) is also shown.
(XLS)
Table S5 DAVID gene ontology analysis of significant
CbCln6
nclf probes. The significantly enriched (p,0.01) gene
ontology terms (GOTERM/Term) from the Biological Process
and Cellular Component categories are shown, determined
through analysis of the significant CbCln6
nclf/nclf probes in DAVID
Bioinformatics Resources 6.7. The number of probes (and the %
of the total) that were represented by the GO term (Probe Count)
is indicated, and the Probe-IDs are listed (Probes). The relative
enrichment value (Fold Enrichment) is also shown.
(XLS)
Table S6 Significantly altered gene sets identified by
sigPathway analysis of the CbCln3
Dex7/8 dataset. The
significantly altered (q-value,0.01) gene sets, and associated
statistics details, are shown for the CbCln3
Dex7/8 cells. For
comparison, the statistics for these same gene sets are shown for
the CbCln6
nclf cells. For a complete description of the NTk and
NEk value determinations, see Materials and Methods.
(XLS)
Table S7 Significantly altered gene sets identified by
sigPathway analysis of the CbCln6
nclf dataset. The
significantly altered (q-value,0.01) gene sets, and associated
statistics details, are shown for the CbCln6
nclf cells. For
comparison, the statistics for these same gene sets are shown for
the CbCln3
Dex7/8 cells. For a complete description of the NTk and
NEk value determinations, see Materials and Methods.
(XLS)
Table S8 Primers used for qRT-PCR validation of
expression array hits. For each selected gene target, primers
used for qRT-PCR experiments are shown, with the sequence in
the 59 to 39 orientation.
(DOC)
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